FDA Approved: SELZENTRY — Supplemental Application (ViiV Healthcare Company)

View source ↗

Summary

The FDA approved a supplemental application for SELZENTRY (maraviroc) submitted by ViiV Healthcare. The approval results in changes to the labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Selzentry (Maraviroc)

Snippet

SUPPL AP for SELZENTRY (MARAVIROC)